In addition, an important advantage of allogeneic over autologous products is that contamination of the product with the patient’s tumour cells is avoided, since a case has been described in which a neoplastic cell was transduced with an anti-CD19 CAR, masking the cell’s own CD19 molecules and becoming resistant to therapy [108]. Here, CD19 is linked to neoplasm.